Keyphrases
Rheumatoid Arthritis
98%
Osteomyelitis
80%
Hazard Ratio
63%
Confidence Interval
62%
Infective Endocarditis
62%
Trauma
54%
Veterans Affairs
53%
National Cohort
51%
Risk Factors
50%
Vancomycin
50%
Infectious Complications
50%
Infectious Diseases
41%
Disease Outcome
38%
Retrospective Cohort Study
33%
High Risk
33%
Hospitalization
33%
International Collaboration on Endocarditis
33%
Daptomycin
33%
Myocardial Infarction
33%
Methicillin-resistant Staphylococcus Aureus
33%
Acute Infective Endocarditis
33%
Mycobacterium Intracellulare
33%
Warfarin
33%
Bisphosphonates
31%
Military Personnel
30%
Risk of Death
30%
Department of Defense
28%
Veterans Health Administration
27%
Trauma-related Infections
27%
TNF-α Antagonists
26%
Enterococcus
25%
Kidney Function
25%
Bloodstream Infection
25%
Polytrauma
25%
Endocarditis
24%
Department of Veterans Affairs
24%
Antibiotics
22%
Bisphosphonate Therapy
20%
US Military
19%
Urinary Tract Infection
19%
Cellulitis
19%
Diabetic
18%
Adverse Drug Events
18%
Tumor Necrosis Factor-α
18%
Heart Valve Prosthesis
18%
Enterococcal Endocarditis
17%
Genitourinary Injury
17%
Rheumatoid Arthritis Patients
17%
Military
17%
Co-prescription
17%
Medicine and Dentistry
Infection
100%
Veterans Affairs
65%
Rheumatoid Arthritis
64%
Inflammatory Arthritis
64%
Infective Endocarditis
62%
Injury
57%
Diseases
54%
Infectious Complication
50%
Endocarditis
50%
Osteomyelitis
44%
Outpatient
41%
Kidney Function
33%
Mycobacterium Avium Complex
33%
Bloodstream Infection
33%
Prevalence
32%
Mental Health
30%
Tumor Necrosis Factor
27%
Hazard Ratio
25%
Bisphosphonate
25%
Clostridium Difficile Infection
25%
Polytrauma
25%
Congestive Heart Failure
24%
Health Care
20%
Urinary Tract Infection
18%
Adverse Drug Reaction
18%
Heart Valve Prosthesis
18%
Genitourinary Trauma
17%
Observational Study
17%
Treatment Duration
16%
Antibiotic Resistance
16%
Coronavirinae
16%
Masking
16%
Community-Acquired Pneumonia
16%
COVID-19 Vaccine
16%
Diuresis
16%
Internal Transcribed Spacer
16%
Disseminated Herpes Zoster
16%
Health Care Facility
16%
Peptoclostridium difficile
16%
Cellulitis
16%
Musculoskeletal Pain
16%
Human Immunodeficiency Virus
16%
Septic Arthritis
16%
Myocardial Infarction
16%
Mental Disorder
16%
Endoscopic Retrograde Cholangiopancreatography
16%
Cardiovascular System
16%
Surveillance System
16%
Joint Injection
16%
Non Melanoma Skin Cancer
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
99%
Inflammatory Arthritis
99%
Infection
99%
Tumor Necrosis Factor
61%
Diseases
50%
Vancomycin
50%
Osteomyelitis
44%
Bisphosphonic Acid Derivative
41%
Cohort Study
35%
Injury
33%
Infectious Complication
33%
Daptomycin
33%
Heart Infarction
33%
Warfarin
33%
Bacterial Endocarditis
28%
Peripheral Occlusive Artery Disease
20%
Congestive Heart Failure
20%
Adverse Drug Reaction
18%
Diabetes Mellitus
18%
Observational Study
17%
Antibiotics
16%
Acute Heart Failure
16%
Community Acquired Pneumonia
16%
Antimicrobial Resistance
16%
COVID-19 Vaccine
16%
Piperacillin Plus Tazobactam
16%
Diffuse Large B Cell Lymphoma
16%
Cancer Mortality
16%
Case-Control Study
16%
Acute Kidney Failure
16%
Head and Neck Cancer
16%
HIV
16%
Lactam
16%
Musculoskeletal Pain
16%
Herpes Zoster
16%
Obesity
16%
Cancer Recurrence
16%
Antiinfective Agent
16%
Non Melanoma Skin Cancer
16%
Cefepime
16%
Methicillin-Resistant Staphylococcus Aureus
16%
Diarrhea
16%
Infectious Diarrhea
16%
Endocarditis
16%
Gram Negative Bacterium
16%
Recurrent Disease
14%
Cardiovascular Disease
12%
Diuretics
11%
Immunosuppressive Agent
9%
Adverse Event
9%
